AIC
INSY

Ameritas Investment Company’s Insys Therapeutics, Inc. INSY Stock Holding History

Ameritas Investment Company’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-115
Closed -$1K – 983
2019
Q1 		$1K Sell
115
-585
-84% -$2.77K ﹤0.01% 925
2018
Q4 		$2K Buy
+700
New +$4.87K ﹤0.01% 1395

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Ameritas Investment Company's INSY Position: Q2 2019 in Review

Ameritas Investment Company sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 115 shares — an estimated $1K sold.

Ameritas Investment Company first reported a position in INSY in Q4 2018 and held it in 2 quarters. The position peaked at $2K in Q4 2018. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Ameritas Investment Company reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 115 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $1K.
  • Ameritas Investment Company first reported a position in Insys Therapeutics, Inc. in Q4 2018 and held it in 2 quarters.
  • Ameritas Investment Company's Insys Therapeutics, Inc. position peaked at $2K in Q4 2018.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Ameritas Investment Company's 13F filing for Q2 2019, filed 7 Aug 2019.